322 related articles for article (PubMed ID: 22612236)
21. Figulla PFO occluder versus Amplatzer PFO occluder for percutaneous closure of patent foramen ovale.
Saguner AM; Wahl A; Praz F; de Marchi SF; Mattle HP; Cook S; Windecker S; Meier B
Catheter Cardiovasc Interv; 2011 Apr; 77(5):709-14. PubMed ID: 20931665
[TBL] [Abstract][Full Text] [Related]
22. [Transcatheter closure of atrial septal defects in adults. Practicality and safety of four different closure systems used in 102 patients].
La Rosée K; Krause D; Becker M; Beuckelmann DJ; Deutsch HJ; Höpp HW
Dtsch Med Wochenschr; 2001 Sep; 126(38):1030-6. PubMed ID: 11565056
[TBL] [Abstract][Full Text] [Related]
23. Occlutech percutaneous patent foramen ovale closure: Safety and efficacy registry (OPPOSE).
Hildick-Smith D; Williams T; MacCarthy P; Melikian N; Monaghan M; Spence M; MacDonald ST; Duke A; Kovac J; McGregor A; Hilling-Smith R; Gomes A; Thomson C; Mullen M; Morrison L
Int J Cardiol; 2017 Oct; 245():99-104. PubMed ID: 28778466
[TBL] [Abstract][Full Text] [Related]
24. Percutaneous transcatheter closure of interatrial septal defect in adults: procedural outcome and long-term results.
Kefer J; Sluysmans T; Hermans C; El Khoury R; Lambert C; Van de Wyngaert F; Ovaert C; Pasquet A
Catheter Cardiovasc Interv; 2012 Feb; 79(2):322-30. PubMed ID: 21523898
[TBL] [Abstract][Full Text] [Related]
25. ASD and PFO closure with the Solysafe septal occluder - results of a prospective multicenter pilot study.
Ewert P; Söderberg B; Dähnert I; Hess O; Schuler G; Bussmann C; Bernhard J; Sick P
Catheter Cardiovasc Interv; 2008 Feb; 71(3):398-402. PubMed ID: 18288739
[TBL] [Abstract][Full Text] [Related]
26. Initial clinical experience with the GORE septal occluder for the treatment of atrial septal defects and patent foramen ovale.
Freixa X; Ibrahim R; Chan J; Garceau P; Dore A; Marcotte F; Mercier LA; Mongeon FP; Basmadjian A; Khairy P; Asgar AW
EuroIntervention; 2013 Sep; 9(5):629-35. PubMed ID: 24058079
[TBL] [Abstract][Full Text] [Related]
27. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism.
Chatterjee T; Petzsch M; Ince H; Rehders TC; Körber T; Weber F; Schneider H; Auf der Maur C; Nienaber CA
J Interv Cardiol; 2005 Jun; 18(3):173-9. PubMed ID: 15966921
[TBL] [Abstract][Full Text] [Related]
28. Five-year clinical and echocardiographic evaluation of the Das AngelWings atrial septal occluder.
Kay JD; O'Laughlin MP; Ito K; Wang A; Bashore TM; Harrison JK
Am Heart J; 2004 Feb; 147(2):361-8. PubMed ID: 14760337
[TBL] [Abstract][Full Text] [Related]
29. "One-stop shop": safety and efficacy of combining atrial septal defect occlusion and left atrial appendage closure for patients with atrial septal defect and atrial fibrillation.
Zhang ZH; Yao Q; Huang HY; Zhu P; Xu X; Song ZY; Li HK
BMC Cardiovasc Disord; 2020 Oct; 20(1):444. PubMed ID: 33045999
[TBL] [Abstract][Full Text] [Related]
30. Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism.
Spies C; Timmermanns I; Reissmann U; van Essen J; Schräder R
Catheter Cardiovasc Interv; 2008 Feb; 71(3):390-5. PubMed ID: 18288745
[TBL] [Abstract][Full Text] [Related]
31. Patent foramen ovale closure using a bioabsorbable closure device: safety and efficacy at 6-month follow-up.
Van den Branden BJ; Post MC; Plokker HW; ten Berg JM; Suttorp MJ
JACC Cardiovasc Interv; 2010 Sep; 3(9):968-73. PubMed ID: 20850098
[TBL] [Abstract][Full Text] [Related]
32. Exclusion of patients with arteriosclerosis reduces long-term recurrence rate of presumed arterial embolism after PFO closure.
Dubiel M; Bruch L; Liebner M; Schmehl I; Winkelmann A; Rux S; Sonntag S; Wulff H; Grad MO; Kleber FX
J Interv Cardiol; 2007 Aug; 20(4):275-81. PubMed ID: 17680857
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcome of transcatheter patent foramen ovale closure in patients with paradoxical embolism.
Cifarelli A; Musto C; Parma A; Pandolfi C; Pucci E; Fiorilli R; De Felice F; Nazzaro MS; Violini R
Int J Cardiol; 2010 Jun; 141(3):304-10. PubMed ID: 19178959
[TBL] [Abstract][Full Text] [Related]
34. Safety of Occlutech Septal Occluder ACCELL Flex II for Transcatheter Closure of Secundum Atrial Septal Defects in Children: A Long-Term Follow-Up.
El-Sisi AM; El-Saiedi SA; Ammar R; Abdelhameed A; Hijazi ZM; Soliman MM
J Interv Cardiol; 2022; 2022():8886813. PubMed ID: 35069039
[TBL] [Abstract][Full Text] [Related]
35. Patent foramen ovale closure with the Occlutech Figulla flex II device: A long-term (up to 10-years) follow-up.
Trabattoni D; Gili S; Calligaris G; Teruzzi G; Troiano S; Ravagnani P; Santagostino Baldi G; Montorsi P
Int J Cardiol; 2023 Sep; 387():131116. PubMed ID: 37301447
[TBL] [Abstract][Full Text] [Related]
36. Figulla ASD occluder versus Amplatzer Septal Occluder: a comparative study on validation of a novel device for percutaneous closure of atrial septal defects.
Pac A; Polat TB; Cetin I; Oflaz MB; Balli S
J Interv Cardiol; 2009 Dec; 22(6):489-95. PubMed ID: 19735475
[TBL] [Abstract][Full Text] [Related]
37. Percutaneous closure of atrial septal defects: immediate and mid-term results.
Dardas PS; Ninios VN; Mezilis NE; Tsikaderis DD; Thanopoulos VD
Hellenic J Cardiol; 2010; 51(2):104-12. PubMed ID: 20378511
[TBL] [Abstract][Full Text] [Related]
38. Effect of percutaneous atrial septal defect and patent foramen ovale device closure on degree of aortic regurgitation.
Loar RW; Johnson JN; Cabalka AK; Cetta F; Hagler DJ; Eidem BW; Taggart NW
Catheter Cardiovasc Interv; 2013 Jun; 81(7):1234-7. PubMed ID: 23239614
[TBL] [Abstract][Full Text] [Related]
39. Intermediate term follow-up on transcatheter closure of atrial septal defects by Amplatzer septal occluder.
Durongpisitkul K; Soongswang J; Laohaprasitiporn D; Nana A
J Med Assoc Thai; 2000 Sep; 83(9):1045-53. PubMed ID: 11075972
[TBL] [Abstract][Full Text] [Related]
40. Percutaneous closure of patent foramen ovale with a bioabsorbable occluder device: single-centre experience.
Ussia GP; Cammalleri V; Mulè M; Scarabelli M; Barbanti M; Scardaci F; Mangiafico S; Immè S; Capodanno D; Tamburino C
Catheter Cardiovasc Interv; 2009 Oct; 74(4):607-14. PubMed ID: 19360875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
